Therefore, it is expected that by increasing adherence to the DRRS and improving insulin resistance and reduced inflammation, a decrease in AgRP levels be observed; interestingly, after adjustment for the confounders, serum AgRP concentrations reduced in higher quartiles of DRRS in a marginally significant threshold (p = 0.065). The gene discussed is AGRP; the disease is Insulin resistance.